Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 3.253B
March 31, 2026 3.28B
December 31, 2025 3.331B
September 30, 2025 3.468B
June 30, 2025 3.534B
March 31, 2025 3.599B
December 31, 2024 3.715B
September 30, 2024 3.734B
June 30, 2024 3.718B
March 31, 2024 3.747B
December 31, 2023 3.748B
September 30, 2023 3.738B
June 30, 2023 3.817B
Date Value
March 31, 2023 3.846B
December 31, 2022 3.894B
September 30, 2022 4.106B
June 30, 2022 4.111B
March 31, 2022 4.149B
December 31, 2021 4.09B
September 30, 2021 4.015B
June 30, 2021 4.108B
March 31, 2021 4.146B
December 31, 2020 4.43B
September 30, 2020 3.388B
June 30, 2020 2.304B
March 31, 2020 1.231B

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Merck & Co., Inc. 48.01B
Viatris, Inc. 5.838B
Pfizer Inc. 41.30B
Pacira Biosciences, Inc. 533.72M
Bristol Myers Squibb Co. 32.78B